首页|信必可在慢性阻塞性肺疾病稳定期治疗与干预效果分析

信必可在慢性阻塞性肺疾病稳定期治疗与干预效果分析

扫码查看
目的 探讨分析信必可在慢性阻塞性肺疾病稳定期的治疗和干预效果.方法 选取2014年6月~2016年5月本院治疗的COPD稳定期的患者80例,将其随机分为对照组和实验组,每组各40例.对照组患者单纯的采用信必可进行治疗,并对患者实施常规护理,实验组患者采用信必可联合百令胶囊进行治疗,并实施针对性护理干预措施,对2组患者的治疗效果以及护理满意度进行比较.结果 实验组患者的临床治疗总有效率为95.0%,护理满意度为97.5%,对照组患者的临床治疗总有效率为80.0%,护理满意度为87.5%,实验组明显高于对照组,差异具有统计学意义(P<0.05).结论 对COPD稳定期采用信必可对其实施治疗,可以有效改善患者的肺功能,提高临床治疗效果,在临床上值得推广应用.
Effect of treatment and intervention on COPD in stable phase with chronic obstructive pulmonary disease
Objective To investigate the analysis of Symbicort in stable stage of chronic obstructive pulmonary disease treatment and intervention. Methods 80 patients with chronic obstructive pulmonary disease in stable period from June 2014-2016 year in May in our hospital were randomly divided into control group and experimental group, 40 cases in each group. The control group of patients with the use of simple Symbicort treatment and routine nursing care to patients, patients in the experimental group using Symbicort combined with Bailing Capsule for treatment, and the implementation of targeted nursing intervention measures, compare the effect of two groups of patients and nursing satisfaction. Results the clinical treatment of patients in the experimental group the total efficiency 95.0%, nursing satisfaction was 97.5%, the control of clinical patients in the treatment group the total effective rate was 80.0%, nursing satisfaction was 87.5%, the experimental group was significantly higher than the control group, the difference was statistically significant (P<0.05). Conclusion Chronic In the stable period of obstructive pulmonary disease, the combination of Xin Yi capsule combined with Bailing capsule can effectively improve the pulmonary function of patients and improve the clinical therapeutic effect, and is worthy of popularization and application in clinic.

symbicortbailing capsuleCOPDtreatmentintervention effect

朱丽、黄依馨、林健

展开 >

台州恩泽医疗中心(集团)台州医院 呼吸内科,浙江 台州 317000

信必可 百令胶囊 慢性阻塞性肺疾病 治疗 干预效果

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(8)
  • 4
  • 5